Q Chip
Commercializes innovative sustained-release drug formulations of injectable therapeutics.
loading funding rounds…
Jon Moulton(exited)
Sir Harry Solomon(exited)
Ken Powell(exited)
Nedermaas Hightech Ventures(exited)
Limburg Ventures(exited)
Finance Wales(exited)
E-Synergy(exited)
Brightlands Venture Partners(exited)
Cardiff University(exited)
Disruptive Capital(exited)
Development Bank of Wales(exited)
| GBP | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (91 %) | - | - | 581 % | 226 % | 21 % | (45 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (12372 %) | (14954 %) | (22863 %) | (1902 %) | 3333 % | (252 %) | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (12043 %) | (11854 %) | (18955 %) | (1682 %) | 3354 % | (251 %) | (254 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads